Study 05 Group[Corporate Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes.

Matthaei S, Bowering K, Rohwedder K, Sugg J, Parikh S, Johnsson E; Study 05 Group. Matthaei S, et al. Diabetes Obes Metab. 2015 Nov;17(11):1075-84. doi: 10.1111/dom.12543. Epub 2015 Sep 4. Diabetes Obes Metab. 2015. PMID: 26212528 Clinical Trial.

Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.

Matthaei S, Bowering K, Rohwedder K, Grohl A, Parikh S; Study 05 Group. Matthaei S, et al. Diabetes Care. 2015 Mar;38(3):365-72. doi: 10.2337/dc14-0666. Epub 2015 Jan 15. Diabetes Care. 2015. PMID: 25592197 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters